ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0702

Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study

Yanint Raksadawan, Sabahat Usmani, Harigopal Sandhyavenu, Thatiana Schulze Goni, Jalpan Patel, Hafiz Muhammad Waqar Younas and Amro Taha, Weiss Memorial Hospital, Chicago, IL

Meeting: ACR Convergence 2023

Keywords: giant cell arteritis, Myocardial Infarction, Myopathies, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiac disease has been known to be a major morbidity and mortality cause in vasculitis. Large vessel vasculitis is mostly associated with pericarditis, myocarditis and valvular disease. The impact of association between LVV and CHF is less studied. 15-50% of Takayasu arteritis patients have aortic insufficiency and cases have been reported where patients present with acute congestive heart failure secondary to aortic insufficiency as their presenting symptom. On the other hand, the incidence of cardiac involvement in Giant Cell arteritis is less compared to Takayasu. Generally, there is a paucity of data due to the rarity of cases. Our study attempted to determine the association of CHF and LVV in one of the largest datasets available in the country.

Methods: National inpatient sample database from 2016-2019 was queried to identify patients with a primary diagnosis of CHF and stratified based on the presence of LVV. The adjusted odds ratios (aOR) of in-hospital outcomes were calculated using chi-square statistics in software STATA v.17.

Results: Of 1,276,429 patients with CHF, 669 had LVV (Giant cell arteritis: 619 and Takayasu arteritis: 50). CHF with LVV patients were older (78.32 vs 70.72, p-value 0.00) and predominantly female (71.6% vs 48%, p-value 0.00). On adjusted analysis, compared to non-LVV patients, LVV patients had significantly higher acute myocardial infarction (AMI) (aOR 2.2, 95%CI 1.19-3.93). There was no difference in major adverse cardiac and cerebrovascular events (aOR 1.31, 95%CI 0.75-2.30), in-hospital mortality (aOR 0.25, 95% CI 0.028-1.40), stroke (aOR 3.97, 95% CI 0.97-16.21), or cardiogenic shock (aOR 0.69, 95%CI 0.16-2.94) between the two groups.

Conclusion: Large vessel vasculitis has no effect on in-hospital outcomes in CHF patients, except for a significant increase in risk for AMI.

Supporting image 1

Supporting image 2


Disclosures: Y. Raksadawan: None; S. Usmani: None; H. Sandhyavenu: None; T. Goni: None; J. Patel: None; H. Waqar Younas: None; A. Taha: None.

To cite this abstract in AMA style:

Raksadawan Y, Usmani S, Sandhyavenu H, Goni T, Patel J, Waqar Younas H, Taha A. Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/large-vessel-vasculitis-increases-risk-of-acute-myocardial-infarction-in-patients-admitted-for-congestive-heart-failure-a-nationwide-inpatient-database-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/large-vessel-vasculitis-increases-risk-of-acute-myocardial-infarction-in-patients-admitted-for-congestive-heart-failure-a-nationwide-inpatient-database-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology